ZINC THERAPY- pyrithione zinc soap

Zinc Therapy by

Drug Labeling and Warnings

Zinc Therapy by is a Otc medication manufactured, distributed, or labeled by D3 Development, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

ACTIVE INGREDIENT

Active ingredient

Pyrithione zinc 2%

PURPOSE

Purpose

Dandruff, Seborrheic dermatitis

INDICATIONS & USAGE

Uses

Controls and reduces the symptoms of dandruff and seborrheic dermatitis.

WARNINGS

Warnings

For external use only

ASK DOCTOR

Ask a doctor before use if you have a condition that covers a large area of the body.

WHEN USING

When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

STOP USE

Stop use and ask a doctor if condition worsens or does not improve after regular use as directed.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION

Directions

• Use on affected areas in place of your regular soap
• For best results use at least twice a week or as directed by a doctor
• Work up a lather using warm water and massage into affected areas
• Rinse well

STORAGE AND HANDLING

Other information

• Store at room temperature
• Lot number and expiration date are printed on back panel.

INACTIVE INGREDIENT

Inactive ingredients

Sodium palmate, sodium cocoate*, sodium palm kernelate*, water, glycerin, titanium dioxide, Avena Sativa (oat) kernel flour, olive oil, vitamin E, table salt, pentasodium pentetate

QUESTIONS

Questions?

1-800-827-3730

www.dermaharmony.com

SPL UNCLASSIFIED SECTION

Distributed by:

D3 Development, Inc., Portland, ME 04101

Made in the USA

PRINCIPAL DISPLAY PANEL

dermaharmony

Zinc Therapy SOAP

2% Pyrithione Zinc for Seborrheic Dermatitis & Dandruff

NET WT 4.0 OZ (113 G)

INGREDIENTS AND APPEARANCE

ZINC THERAPY 
pyrithione zinc soap

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 71819-001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
PYRITHIONE ZINC (UNII: R953O2RHZ5) (PYRITHIONE ZINC - UNII:R953O2RHZ5)	PYRITHIONE ZINC	2 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
SODIUM CHLORIDE (UNII: 451W47IQ8X)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
WATER (UNII: 059QF0KO0R)
SODIUM COCOATE (UNII: R1TQH25F4I)
GLYCERIN (UNII: PDC6A3C0OX)
OATMEAL (UNII: 8PI54V663Y)
SODIUM PALM KERNELATE (UNII: 6H91L1NXTW)
OLIVE OIL (UNII: 6UYK2W1W1E)
SODIUM PALMATE (UNII: S0A6004K3Z)
.ALPHA.-TOCOPHEROL ACETATE, D- (UNII: A7E6112E4N)
PENTASODIUM PENTETATE (UNII: 961TOZ5L7T)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 71819-001-01	28 g in 1 CELLO PACK; Type 0: Not a Combination Product	05/01/2018
2	NDC: 71819-001-04	113 g in 1 CELLO PACK; Type 0: Not a Combination Product	05/01/2018
3	NDC: 71819-001-44	226 g in 1 CELLO PACK; Type 0: Not a Combination Product	03/24/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part358H	05/01/2018

Labeler - D3 Development, Inc. (043195877)